Company Atrinsic, Inc. Other OTC
Equities
US04964C2089
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 31/01/16 |
Andrew Slee
COO | Chief Operating Officer | 74 | 31/01/16 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 11/02/16 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 02/02/94 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 11/02/16 |
Brian Corvese
BRD | Director/Board Member | 67 | 27/07/17 |
Khalil Barrage
BRD | Director/Board Member | 59 | 30/06/07 |
Timothy Wright
BRD | Director/Board Member | 66 | 22/11/22 |
Jennifer Buell
BRD | Director/Board Member | 50 | 17/07/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,435,132 | 3,466,915 ( 78.17 %) | 0 | 78.17 % |
Company contact information
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.comSector
1st Jan change | Capi. | |
---|---|---|
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- PTIX Stock
- Stock
- Company Atrinsic, Inc.